Founded in 2019, Grannus Therapeutics is a pre-clinical stage biotechnology company, focused on the development of small molecule inhibitors for specific isoforms of HSP90. Our lead program is focused on the development of a highly selective small molecule inhibitor of HSP90𝛽 for the treatment of multiple types of cancer. With this program, we have successfully engineered a molecule that selectively inhibits HSP90𝛽, potentially delivering the efficacy benefits of previous pan-inhibitors without their toxicity and dosing challenges.
Company Details
- Employees
- 3
- Founded
- 2019
- Address
- Indianapolis, In, Us
- Industry
- Biotechnology
- HQ
- Indianapolis, IN
Grannus Therapeutics Questions
Grannus Therapeutics's LinkedIn profile is https://www.linkedin.com/company/grannus-therapeutics
Grannus Therapeutics has
3 employees.
View email and phone details for 3
employees at Grannus Therapeutics.
Grannus Therapeutics's industry is
Biotechnology
Grannus Therapeutics's top competitors are
Tayco Brace,
Amplified Sciences, Inc.,
Adipo Therapeutics,
Ascent Integrated Tech,
Elevate Ventures,
Sizzle,
Relate Xr,
Insignum Agtech,
Geniphys,
Zila Bioworks.
Grannus Therapeutics's categories are Biotechnology
Grannus Therapeutics's founding year is 2019
